Angiogenesis pp 283-289 | Cite as

In Vivo Assays for Angiogenesis

  • Wanda Auerbach
  • Robert Auerbach
Part of the NATO ASI Series book series (NSSA, volume 263)


Angiogenesis, the formation of new blood vessels, is an important element of a large number of normal and disease processes. The most dramatic physiologically normal angiogenesis occurs during the development of the placental and embryonic vasculature. The most striking disease-associated angiogenesis is seen in the growth of solid tumors. But angiogenesis also accompanies normal processes such as the cyclical changes of the endometrium and the hair follicle, and the reparative events involved in the healing of wounds. The range of angiogenesis-associated disease processes is even broader: Angiogenesis is seen in sites of immunological activity ranging from autoimmune diseases to inflammation; it is almost universally associated with ocular diseases and injury, it is prominent in psoriasis and scleroderma, and it is a hallmark of granulomatous lesions. Studies of angiogenesis and its inhibition are therefore an integral part of numerous research programs both in academic institutions and in pharmaceutical firms interested in the development of angiogenic or anti-angiogenic strategies.


Alginate Bead Corneal Neovascularization Divarication Site Sodium Alginate Bead Embryonic Vasculature 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Auerbach, R., Auerbach, W., and Polakowski, I., 1991, Assays for angiogenesis: a review, Phanmacol. Ther. 51: 1 - 11.CrossRefGoogle Scholar
  2. Auerbach, W., and Auerbach, R., 1994, Angiogenesis inhibition: A review, Phannacol. Therapeut. (in press).Google Scholar
  3. D’Amato, R., Wesolowski, E., and Hodgson-Smith, L.E., 1993, Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc. Res. 46: 135 - 142.PubMedCrossRefGoogle Scholar
  4. Downs, E.C., Robertson, N.E., Riss, T.L., and Plunkett, M.L., 1992, Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro, J. Cell. Physiol. 152: 422–429.PubMedCrossRefGoogle Scholar
  5. Fajardo, L.F., Kowalski, J., Kwan, H.H., Prionas, S.D. and Allison, A.C., 1988, The disc angiogenesis system, Lab. Invest. 58: 718 - 724.PubMedGoogle Scholar
  6. Fan, T.-P.D., Hu, D.-E., Guard, S., Gresham, GA., and Watling, KJ., 1993, Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NKl or interleukin-1 receptor antagonists, Br. J. Pharmacol. 110: 43 - 49.PubMedCrossRefGoogle Scholar
  7. Gimbrone, MA. Jr., Leapman, S.B., Cotran, R.S. and Folkman, J., 1974, Tumor growth and neovascularization: An experimental model using the rabbit cornea. J. Natl. Cancer Inst. 52: 413–427.PubMedGoogle Scholar
  8. Hu, D.E., Hori, Y., and Fan, T.-P.D., 1993, Interleukin-8 stimulates angiogenesis in rats. Inflammation, 17: 135 - 143.PubMedCrossRefGoogle Scholar
  9. Kowalski, J., Kwan, H.H., Prionas, S.D., Allison, A.C. and Fajardo, L.F., 1992, Characterization and applications of the disc angiogenesis system, Exp. Mol. Pathol. 56: 1 - 19.PubMedCrossRefGoogle Scholar
  10. Malcherek, P. and Franzén, L., 1991, A new model for the study of angiogenesis in connective tissue repair, Microvasc. Res. 42: 217 - 223.PubMedCrossRefGoogle Scholar
  11. Muthukkaruppan, VR., and Auerbach, R., 1979, Angiogenesis in the mouse cornea. Science 205: 1416 - 1418.PubMedCrossRefGoogle Scholar
  12. Passaniti, A., Taylor, R.M., Pili, R., Guo, Y., Long, P.V., Haney, J.V., Pauly, R.R., Grant, D.S. and Martin, G. R., 1992, A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor, Lab. Invest. 67: 519 - 528.PubMedGoogle Scholar
  13. Polakowski, I., Lewis, M.K., Muthukkaruppan, VR., Erdman, B., Kubai, L. and Auerbach, R., 1993, A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice, Am. J. Pathol. 143: 507 - 517.PubMedGoogle Scholar
  14. Proia A.D., Chandler, D.B., Haynes, W.L., Smith, C.F., Suvarenamani, C., Erkel, F.H., and Klintworth, G.K., 1988, Quantitation of corneal neovascularization using computerized image analysis. Lab. Invest. 58: 473 - 479.PubMedGoogle Scholar
  15. Sidky, YA. and Auerbach, R., 1975, Lymphocyte-induced angiogenesis: A quantitative and sensitive assay of the graft-vs.-host reaction, J. Exp. Med. 141: 1084 - 1100.PubMedCrossRefGoogle Scholar
  16. Sidky, YA. and Borden, E.C., 1987, Inhibition of angiogenesis by interferon: effects on tumor-and lymphocyte-induced vascular responses, Cancer Res. 47: 5155 - 5161.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Wanda Auerbach
    • 1
  • Robert Auerbach
    • 1
  1. 1.Center for Developmental BiologyUniversity of WisconsinMadisonUSA

Personalised recommendations